Cardiovascular

FDA permits marking of hand-held scanner for detecting intracranial hematomas

On Dec. 13, the U.S. Food and Drug Administration (FDA) announced it was allowing marketing of the first hand-held device for detecting intracranial hematomas, using near-infrared spectroscopy. Read more.


Related Articles:

Leave a Reply

Your email address will not be published. Required fields are marked *

 

Shares